Advances in the study of marketed antibody-drug Conjugates (ADCs) for the treatment of breast cancer

Advances in the study of marketed antibody-drug Conjugates (ADCs) for the treatment of breast cancer

Breast cancer continues to have a high incidence rate among female malignancies. Despite significant advancements in treatment modalities, the heterogeneous nature of breast cancer and its resistance to various therapeutic approaches pose considerable challenges. Antibody-drug conjugates (ADCs) effe...

Full description

Bibliographic Details
Main Authors: Yan Liang, Purong Zhang, Feng Li, Houyun Lai, Tingting Qi, Yixin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Pharmacology
Subjects:
breast cancer
T-DM1
T-DXd
SG
ADC
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1332539/full

Similar Items

Similar Items